Pharma firms stash profits in Europe's tax havens as patients struggle with drug prices

Investigate Europe finds 15 of the world’s biggest drugmakers operate more than 1,300 subsidiaries in tax havens, as they amassed over €580 billion in global profits over the past five years. Meanwhile, patients face life-threatening delays for medicines due to high drug prices.

Investigate Europe